These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 30118608)

  • 1. Impact of transporters and enzymes from blood-cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake.
    Wang Q; Zuo Z
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):961-972. PubMed ID: 30118608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
    Akanuma SI; Yamazaki Y; Kubo Y; Hosoya KI
    Fluids Barriers CNS; 2018 Jan; 15(1):1. PubMed ID: 29307307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier.
    de Lange EC
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1793-809. PubMed ID: 15381334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics.
    Ronaldson PT; Davis TP
    Expert Opin Drug Deliv; 2024; 21(1):71-89. PubMed ID: 38217410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
    Tachikawa M; Uchida Y; Terasaki T
    Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organic Cation Transporter (OCT/OCTN) Expression at Brain Barrier Sites: Focus on CNS Drug Delivery.
    Betterton RD; Davis TP; Ronaldson PT
    Handb Exp Pharmacol; 2021; 266():301-328. PubMed ID: 33674914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD4
    Nishihara H; Soldati S; Mossu A; Rosito M; Rudolph H; Muller WA; Latorre D; Sallusto F; Sospedra M; Martin R; Ishikawa H; Tenenbaum T; Schroten H; Gosselet F; Engelhardt B
    Fluids Barriers CNS; 2020 Feb; 17(1):3. PubMed ID: 32008573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The barrier and interface mechanisms of the brain barrier, and brain drug delivery.
    Zhang S; Gan L; Cao F; Wang H; Gong P; Ma C; Ren L; Lin Y; Lin X
    Brain Res Bull; 2022 Nov; 190():69-83. PubMed ID: 36162603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood-Cerebrospinal Fluid Barrier and Blood-Brain Barrier.
    Kibathi LW; Bae S; Penzak SR; Kumar P
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):619-635. PubMed ID: 29858835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel localization of folate transport systems in the murine central nervous system.
    Sangha V; Hoque MT; Henderson JT; Bendayan R
    Fluids Barriers CNS; 2022 Nov; 19(1):92. PubMed ID: 36419095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of Drug Transporters to Blood-Brain Barriers.
    Liu L; Liu X
    Adv Exp Med Biol; 2019; 1141():407-466. PubMed ID: 31571171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers.
    Morris ME; Rodriguez-Cruz V; Felmlee MA
    AAPS J; 2017 Sep; 19(5):1317-1331. PubMed ID: 28664465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian ABCG2 Expression Influences the Brain Uptake of Donepezil across the Blood-Cerebrospinal Fluid Barrier.
    Furtado A; Duarte AC; Costa AR; Gonçalves I; Santos CRA; Gallardo E; Quintela T
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.
    Engelhardt B; Sorokin L
    Semin Immunopathol; 2009 Nov; 31(4):497-511. PubMed ID: 19779720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
    Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new in vitro model for blood-cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat.
    Hosoya K; Hori S; Ohtsuki S; Terasaki T
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1875-85. PubMed ID: 15381338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Efflux Transporter Inhibition on the Distribution of Fluconazole in the Rat Brain.
    Wang W; Zheng N; Zhang J; Huang X; Yu S
    Neurochem Res; 2017 Aug; 42(8):2274-2281. PubMed ID: 28337665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug efflux transporters in the CNS.
    Sun H; Dai H; Shaik N; Elmquist WF
    Adv Drug Deliv Rev; 2003 Jan; 55(1):83-105. PubMed ID: 12535575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology.
    Moura RP; Martins C; Pinto S; Sousa F; Sarmento B
    Expert Opin Drug Deliv; 2019 Mar; 16(3):271-285. PubMed ID: 30767695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.